Managing patients with vulvovaginal candidiasis

Nurse Practitioner

Volumn 23, Issue 3, 1998, Pages 44-53

  Elliott, Kelly Ann ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT;

FEMALE; HUMAN; PATIENT COMPLIANCE; PATIENT EDUCATION; PREVALENCE; REVIEW; RISK FACTOR; SELF CARE; VAGINA CANDIDIASIS;

ANTIFUNGAL AGENTS; CANDIDIASIS, VULVOVAGINAL; FEMALE; HUMANS; PATIENT COMPLIANCE; PATIENT EDUCATION; PREVALENCE; RISK FACTORS; SELF CARE;

EID: 0032016275     PISSN: 03611817     EISSN: 15388662     Source Type: Journal    
DOI: 10.1080/19986205-199803000-00003     Document Type: Article

References (37)

1. Sobel JD: Vaginal infections in adult women. Med Clin North Ain 1990;74:1573-602
2. Kent HL: Epidetniology of vaginitis. Am J Obstet Gynccol 1991; 165(suppl 2): 1168-76
3. Horowitz BJ, Giaquinta D, I to S: Evolving pathogens in vulvovaginal candidiasis: implications for patient care. J Clin Pharmacol 1992;32:248-55
4. Sobel JD: Candidal vulvovaginitis. Clin Obstet Gynecol 1993;36:153-65
5. Carcio HA, Secor RMC: Vulvovaginal candidiasis: a current update. Nurse Practitioner Forum 1992;3:135-44
6. Oriel JD, Partridge BM, Denny MJ, et al: Genital yeast infections. BiYlJ 1972;4:761-64
7. Kaufman RH, Hatnniill HA: Vaginitis. Prim Care 1990;17:115-25
8. Horowitz BJ, Edelstein SW, Lippman L: Candida tropicalis vulvovaginitis. Obstet Gynccol 1985;66:229-32
9. Faro S: Systemie vs. topical therapy for the treatment of vulvovaginal candidiasis. J IntMed Res 1984;12:298-302
10. Odds FC: Resistance of yeasts to azole-derivative antifungals. J Antimi-crob Chemother 1993;31:463-71
11. Tobin MJ: Vulvovaginal candidiasis: topical vs. oral therapy. Am Fain Physician 1995;51:1715-20
12. Clissold SP, Heel RC:Tioconazole. A revicw of its antimicrobial activity and therapeutic use in superficial mycoscs. Drugs 1986;31:29-51
13. Abbott M, Hughes DL, Patel R, et al: Angioedema after fluconazole [let-tcr]. Lancet 1991;338:633
14. Neuhaus G, Pavic N, Pletscher M: Anaphylactic reaction after oral flu-conazole [Ietter]. BMJ 1991;302:134-1
15. Hay RJ Risk/benefit ratio of modera antifungal therapy: Focus on hepatic reactions. J Am Acad Dennatol 1993;29:S50-54
16. Reef SE, Levine WC, NeNeil MM, et al: Treatment options for vulvovaginal candidiasis, 1993. Clin Infect Dis 1995;20(suppl 1):S80-90
17. Hunt IM, Jordan B, Irwin S, et al: Compliance and the patienrt perspective; controlling symptoms in everyday life. Cult Med Psychiatry 1989;13:315-34
18. Nixon SA: Vulvovaginitis. The role of paticnt compliance in treatment suc-cess. AmJ Obstet Gynecol 1991;165:1207-09
19. Sobel J (ed): Clinical Perspectives. Tcrconazole, an Advance in Vulvovaginal Candidiasis Therapy. New York: BiMIAVlcGraw Hill, 1988
20. Clarke C, Cooper CL, Gordon SF, et al: A multicenter comparison of one-dose tioconazole ointment with three-dose terconazolc cream in vulvovaginal candidiasis. J Women fel Health 1993;2:189-96
21. Rhode-Wemer H: Topical tioconazole versus systemic ketoconazole treatment of vaginal candidiasis. J Inti Med Res 1984;12:298-302
22. Stein GE, Gurwith D, Mummaw N, et al: Single-dose tioconazole com-pared to 3-day clotrimazole treatment in vulvovaginal candidiasis. Antimi-crob Agents Chemother 1986;29:969-71
23. Loendersloot MD, Goormans E, Wiesenhaan PE, et al: Efficacy and tol-erability of single-dose versus 6-day treatment of candidal vulvovaginitis with vaginal tablets of clotrimazole. AmJ Obstet Gynecol 1985; 152:953-55
24. Bingham JS: Single-blind comparison of ketoconazole 200 mg oral tablets and clotrimazole 100 mg vaginal tablets and 1% cream in treating acute vaginal candidosis. BrJ Vener Dis 1984;60:175-77
25. Puolakka J, Tuimala R: A comparison between oral ketoconazole and topical miconazole in the treatment of vaginal candidiasis. Acta Obstet Gy-nccol Scand 1983;62:575-77
26. Van Heusden AM, Merkus HMWM, Corbeij RSACM, et al: Single-dose oral fluconazole versus single-dose topical miconazole for the treatment of acute vulvovaginal candidosis. Acta Obstet Gynecol Scand 1990;69:417-418
27. Lee B, Feinberg M, Abraham J, et al: Congenital malformations in an in-fant bom to a woman treated with fluconazole. Pediatr Infect Dis 1992;11:1062-64
28. Pursley TJ, Blomquist IK, Abraham J, et al: Fluconazole-induced congenital anomalies in three infants. Clin Infect Dis 1996;22:336-40
29. Sobel JD: Recurrent vulvovaginal candidiasis. A prospective study of the efficacy of maintenance ketoconazole therapy. N EngI J Med 1986;315:1455-58
30. Sobel JD: Fluconazole maintenance therapy in recurrent vulvovaginal candidiasis. IntJ Gynecol Obstet 1992;37(suppl):17-24
31. Sobel JD: Management of recurrent vulvovaginal candidiasis with inter-mittent ketoconazole prophylaxis. Obstet Gynecol 1985;65:435-40
32. Horowitz BJ, Edelstein SW, Lippman L: Sexual transmission of Candida. Obstet Gynecol 1987;69:883-86
33. Calderson-Marquez JJ: Itraconazole in the treatment of vaginal candidosis and the effect of treatment of the sexual partner. Rev Infect Dis 1987;9(suppl 1):143-45
34. Lichtman R, Papera S (eds): Gynecology: Well-Woman Care. Stamford, Conn: Appleton-Lange, 1990:191
35. Mindell, E: Earl MindelFs Herb Bible. New York, NY: Simon & Schus-ter/Fireside, 1992
36. Kistner RW (ed): Gynecology: Principies and Practice, 4th ed. Chicago, 111: Year Book Medicai Publisher, 1986:38
37. Tenney L: Today’s Herbal Health, 3rd ed. Provo, Utah: Woodland Books, 1992